 Medical device company Minerva Surgical Inc NASDAQ: UTRS expects Q4 FY21 sales of 13.5 million - 13.7 million, versus 13.6 million posted a year ago and the consensus of 13.45 million. FY21 sales are expected to be 52.0 million - 52.2 million prior view 51.0 million - 52.0 million, compared to 37.8 million in FY20 and the consensus of 51.75 million. 